OKYO — OKYO Pharma Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeSmall Cap
- $98.44m
- $97.62m
2018 March 31st | 2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -20.2 | -3.76 | -1.27 | -3.02 | -4.55 |
Depreciation | |||||
Non-Cash Items | 19 | 2.1 | 0.178 | 0.903 | 1.32 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.025 | 0.136 | 0.13 | 0.859 | -0.75 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Cash from Operating Activities | -1.14 | -1.53 | -0.961 | -1.24 | -3.98 |
Capital Expenditures | 0 | -0.001 | 0 | -0.005 | -0.001 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | -0.104 | -0.009 | 0 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | -0.001 | -0.104 | -0.014 | -0.001 |
Financing Cash Flow Items | — | — | 0 | 0.001 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | — | — | 0.774 | 6.06 | 1.05 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.14 | -1.53 | -0.291 | 4.8 | -2.94 |